Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-LAPS I: Extended vs Short Heparin in Laparoscopic Colorectal Surgery
NCT01589146Phase 3Unknown
- Sponsor
- University of Perugia
- Start
- Sep 2010
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by University of Perugia. Primary endpoint: Incidence of venous thromboembolism or VTE-related death at 30 days. Status: unknown.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01589146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589146.